1. 必一·运动(B-Sports)官方网站

      About US

      关于我们

      1992

      1995

      2003

      2005

      2011

      2012

      2014

      2015

      2016

      2017

      2018

      2019

      2020

      2021

      2022

      1992


      • Hainan Poly Pharm was Founded

      1995


      • Poly Launched its First Product Nimodipine Capsules to Market

      2003


      • Zhejiang Poly Pharm was Established

      2005


      • cGMP Certification Launched to Start a New Journey of Internationalization

      2011


      • Production Line of Ganciclovir Sodium for Injection and its API Passed WHO on-site GMP Inspection

      2012


      • 1. Hainan Poly Pharm Changed to be a Joint-stock Company;

      • 2. Production Line of Ganciclovir Sodium for Injection and its API Passed EU EMA On-site GMP Inspection;

      • 3. Product Approved to WHO pre-qualification Program

      2014


      • Ganciclovir sodium for injection receives EU marketing authorization

      2015


      • Production Line of Lyophilized Powder Injection Passed US FDA Inspection

      2016


      • EU Marketing Authorization Obtained for Levetiracetam Injection

      2017


      • Poly Pharma Successfully Listed in Growth Enterprise Board

      2018

      1. Facility of Hangzhou Poly Pharm Put into Operation;

      2. New Injection Building and Upgraded API Workshop of Hainan Poly Pharm Put into Operation;

      3. API Workshop and Lyophilized Injection Line Passed WHO GMP Follow-up Inspection

      2019

      Anhui Poly Pharm Laid Foundation Stone for its Manufacturing Facility

      2020

      1. First Shippment of Sodium Nitroprusside Injection to the United States;

      2. Bivalirudin for Injection Approved for Marketing in China;

      3. Ganciclovir Sodium for Injection Passed Consistency Evaluation.

      2021

      1. Zhejiang Poly Pharm received EIR for its first pre-approval inspection by FDA

      2. Beijing Pharmaceutical Innovation Platform was jointly established by Institute of High Energy Physics (Chinese Academy of Sciences) and Poly Pharm.

      3. Poly Pharma Steps into DNA Vaccine;

      4. Anqing facility officially start production。

      2022

      1、Celebrating 30th Anniversary of Poly Pharm Group (1992-2020);

      2、Initial Shippment of Esomeprazole Sodium for Injection to the United States;

      3、Sodium Nitroprusside Injection passed the evaluation of bio-equivalence consisteny and approved for marketing in China.

      友情链接: